Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
06/2004
06/03/2004US20040106656 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
06/03/2004US20040106626 amidine containing compounds which inhibit serine proteases
06/03/2004US20040106621 3-Heterocyclic benzylamide derivatives as potassium channel openers
06/03/2004US20040106606 Dihydropyrones with tethered heterocycles
06/03/2004US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent
06/03/2004US20040103820 To enhance light resistance by absorbing ultraviolet (UV) light, provide wettability and stabilize a colorant
06/03/2004DE10254439A1 Tubulysine, Herstellungsverfahren und Tubulysin-Mittel Tubulysins, manufacturing methods and means tubulysin
06/03/2004CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication
06/03/2004CA2503316A1 Method and compositions for temporarily incapacitating subjects
06/03/2004CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
06/02/2004EP1424330A1 Activator for peroxisome proliferator-responsive receptor delta
06/02/2004EP1423370A1 Fxr nr1h4 nuclear receptor binding compounds
06/02/2004EP1423368A1 Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors
06/02/2004EP1423363A1 Oral antidiabetic agents
06/02/2004EP1423356A2 Novel aminobenzoephenones
06/02/2004EP1423113A1 Nr1h4 nuclear receptor binding compounds
06/02/2004EP1087952B1 Benzazole compounds and their use
06/02/2004CN1501980A Degradation of epothilones and ethynyl substituted epothilones
06/02/2004CN1501796A Treatment of type 2 diabetes mellitus using inhibitors of dipeptidyl peptidase IV
06/02/2004CN1501773A Liquid formulations for dernal application in treatment of parasitic insects in animals
06/02/2004CN1152027C Polycyclic thiazole-2-subunit amines, producing process and uses in preparing medicament thereof
06/02/2004CN1152026C Polycyclic 2-amino thiazoline systems, producing process and uses as medicament thereof
06/02/2004CN1152025C Substituted benzylthiazolidine-2,4-dione derivatives
06/02/2004CN1152020C Benzimidazolrone and analogues, and uses as progesterone ligand thereof
06/01/2004US6743939 Phenylheteroalkylamine derivatives
06/01/2004US6743921 Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1-yl)-1-propanol compounds
06/01/2004US6743790 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use
06/01/2004CA2190993C Protective agent for organ or tissue
05/2004
05/27/2004WO2004043939A1 Amide compounds and methods of using the same
05/27/2004WO2004043931A1 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors
05/27/2004WO2004043926A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
05/27/2004WO2004043911A2 N-cycloalkylglycines as hiv protease inhibitors
05/27/2004WO2004043458A1 Bicyclic-substituted amines as histamine-3 receptor ligands
05/27/2004WO2004043362A2 Acyl guanidine compounds and use thereof
05/27/2004WO2004043355A2 Alpha, alpha-disubstituted benzylglycine derivatives as hiv protease inhibitors
05/27/2004US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease
05/27/2004US20040102609 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors
05/27/2004US20040102496 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
05/27/2004US20040102495 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
05/27/2004US20040102493 Compound of formula (I) for the manufacture of a medicament for the prevention or treatment of a hPPAR mediated disease or hypercholesteremia, cardiovascular disease, type II diabetes obesity, anorexia bulimia, inflammation and anorexia
05/27/2004US20040102489 Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
05/27/2004US20040102439 Halogenobenzyl aminopropionic acid derivatives
05/27/2004US20040102437 Prevention cytokine migration; hypotensive agents; asthma therapy
05/27/2004US20040102435 Alzheimer's disease; psychological disorders; anxiolytic agents; antidepressants; hormone replacement therapy
05/27/2004US20040102418 Compounds for the treatment of inflammatory disorders
05/27/2004US20040099609 Chemical process for the extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole
05/27/2004CA2765093A1 Bicyclic-substituted amines as histamine-3 receptor ligands
05/27/2004CA2505361A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
05/26/2004EP1422217A2 Aminocyclohexyl ether compounds and uses thereof
05/26/2004EP1421389A2 Neurofibrillary labels
05/26/2004EP1421071A2 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
05/26/2004EP1421063A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands
05/26/2004EP1420784A1 Compounds effecting glucokinase
05/26/2004EP1420644A1 Substituted propargylamines
05/26/2004EP1173176B1 Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity
05/26/2004EP1005445B1 N-alkanoylphenylalanine derivatives
05/26/2004CN1151140C Glucokinase activators
05/26/2004CN1151139C Novel heterocyclic analogs of diphenylethylene compounds
05/25/2004US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury.
05/25/2004US6740670 Thiazolidine derivatives and its use as antifungal agent
05/25/2004CA2081935C Anilide derivatives and their use for combating botrytis
05/21/2004WO2004041802A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
05/21/2004WO2004041801A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
05/21/2004WO2004041797A1 Process for preparing 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole
05/21/2004WO2004041796A1 Transition metal catalysts for (co)polymerizing olefinic monomers
05/21/2004WO2004041794A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
05/21/2004WO2004041276A1 Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
05/21/2004WO2004041266A1 Receptor function controlling agent
05/21/2004WO2004041264A1 2-oxo-ethanesulfonamide derivates
05/21/2004WO2004041256A2 Safe chemical uncouplers for the treatment of obesity
05/21/2004WO2004041163A2 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
05/21/2004CA2505322A1 Receptor function regulator
05/21/2004CA2503713A1 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
05/21/2004CA2502732A1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
05/20/2004US20040097739 Ppar delta activators
05/20/2004US20040097594 Sulfonamide inhibitors of aspartyl protease
05/20/2004US20040097566 For therapy of diseases related to uncontrolled cellular proliferation, useful for modulating lipid and/or carbohydrate metabolism, for therapy of Type II diabetes, hyperglycemia or obesity, inflammatory diseases such as arthritis
05/20/2004US20040097558 Hetaryl substituted homotetramic and homtetronic acids and the use thereof as pesticides
05/20/2004US20040097508 Novel heterocyclically substituted amides, their preparation and use
05/20/2004US20040097487 To inhibits matrix metalloprotease activity
05/20/2004US20040097376 Controlling weeds
05/19/2004EP1419771A1 Preventive and/or remedial agent for disease attributable to arteriosclerotic activity
05/19/2004EP1419770A1 Apo ai expression accelerating agent
05/19/2004EP1419148A1 M-aminophenol derivatives and colouring agents containing them
05/19/2004EP1418911A1 2,4,5-trisubstituted thiazolyl derivatives ant their antiinflammatory activity
05/19/2004EP1418910A1 Methods for inhibiting or reversing tau filament formation polymerization
05/19/2004EP1418909A2 2-amino-4, 5-trisubstituted thiaolyl derivatives and their use against autoimmune diseases
05/19/2004EP1131308B1 New piperazine and piperidine compounds
05/19/2004EP1000051B1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4
05/19/2004DE10251513A1 Compounds with 5-membered heterocycle linked by amino- or phosphino-methyl to a benzene ring with an ortho-hydroxy, alkoxy, thiol or amino group, used as multidentate ligands in olefin polymerization catalysts
05/19/2004CN1498214A Bicyclic guanidine derivatives and therapeutic uses thereof
05/19/2004CN1498208A Carboxamides as fungicides in agriculture
05/19/2004CN1150281C Azo compounds and process for preparing the same
05/18/2004US6737532 High efficiency blue and green emitters; benzimidazole, benzoxazole, benzthiazole and/or indole derivatives
05/18/2004US6737423 Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them
05/18/2004US6737418 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
05/18/2004US6737382 Insecticidal aminothiazole derivatives
05/13/2004WO2004039795A2 Amide compounds for the treatment of hyperlipidemia
05/13/2004WO2004039789A1 Thiazol-(bi)cycloalkyl-carboxanilides
05/13/2004WO2004022529A3 Diarylurea derivatives and their use as chloride channel blockers